[go: up one dir, main page]

Hilliard et al., 1976 - Google Patents

Effects of luteinizing hormone-releasing hormone on fetal survival in pregnant rabbits

Hilliard et al., 1976

View PDF
Document ID
6922627238523237205
Author
Hilliard J
Pang C
Sawyer C
Publication year
Publication venue
Fertility and Sterility

External Links

Snippet

The effect of synthetic luteinizing hormone-releasing hormone (LH-RH) on ovulation, implantation, and fetal survival rate was tested in pregnant rabbits. Single doses ranging from 2 to 900 μg, injected intravenously on the 3rd, 5th, or 6th postmating day, did not …
Continue reading at www.sciencedirect.com (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/33—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans derived from pro-opiomelanocortin, pro-enkephalin or pro-dynorphin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins

Similar Documents

Publication Publication Date Title
GOODMAN et al. Pulsatile secretion of luteinizing hormone: differential suppression by ovarian steroids
Libertun et al. Biphasic effect of estrogen on the sensitivity of the pituitary to luteinizing hormone-releasing factor (LRF)
Wise et al. Further evidence that luteinizing hormone-releasing hormone also is follicle-stimulating hormone-releasing hormone
Ferin et al. Effects and site of action of morphine on gonadotropin secretion in the female rhesus monkey
Mann et al. Role of estrogen and progesterone in facilitating LH release in 4-day cyclic rats
Gutknecht et al. Antifertility properties of prostaglandin F2α
Siegel et al. Progesterone inhibition of estrogen-induced maternal behavior in hysterectomized-ovariectomized virgin rats
RIVIER et al. Inhibin: measurement and role in the immature female rat
Hilliard et al. Effects of luteinizing hormone-releasing hormone on fetal survival in pregnant rabbits
LUMPKIN et al. Evidence for a hypothalamic site of action of inhibin to suppress FSH release
Spies et al. Luteinizing hormone release and ovulation induced by the intraventricular infusion of prostaglandin E1 into pentobarbital-blocked rats
Billeter et al. Evidence for a luteolytic function of prolactin in the intact cyclic rat using 2-Br-α-ergokryptine (CB 154)
Wallach et al. Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical perspectives
Brown-Grant et al. A comparison of changes in the peripheral plasma concentrations of luteinizing hormone and folliclestimulating hormone in the rat
Happ et al. Treatment of cryptorchidism with pernasal gonadotropin-releasing hormone therapy
BLAKE et al. Administration of antiluteinizing hormone-releasing hormone serum to rats: effects on periovulatory secretion of luteinizing hormone and follicle-stimulating hormone
Mantle Interruption of early pregnancy in mice by oral administration of agroclavine and sclerotia of Claviceps fusiformis (Loveless)
Smith Hypothalamic-pituitary responsiveness during lactation in the rat: estrogen-induced luteinizing hormone surges
Harrington et al. Induction of ovulation in chlorpromazine-blocked rats
EVERETT Reinstatement of estrous cycles in middle-aged spontaneously persistent estrous rats: importance of circulating prolactin and the resulting facilitative action of progesterone
US4673665A (en) Process for treating anestrus in ewes or beef cattle
Schally et al. Determination of CRF activity in rats treated with Monase, dexamethasone, and morphine
Arsenijevic et al. Plasma growth hormone (GH) response to intravenous GH-releasing factor (GRF) in adult rats: evidence for transient pituitary desensitization after GRF stimulation
Banik et al. Effects of a luteinizing hormone-releasing hormone analog on mating and fertility in rats
Sawano et al. Effect of CNS-depressants, dexamethasone and growth hormone on the response to growth hormone-releasing factor